| Inverness Medical Innovations to Attend the Citi Global Health Care Conference on May 26, 2010 (PR Newswire) Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Citi Global Health Care Conference being held May 26 through 27, 2010 at the New York Hilton Hotel in New York City. Â Jon Russell, Vice President, Finance, will attend. us.rd.yahoo.com |
Neogen Corporation F4Q10 (Qtr End 05/31/10) Earnings Call Transcript Neogen Corporation (NEOG)F4Q10 (Qtr End 05/31/10) Earnings CallJune 20, 2010 11:00 am ETComplete Story » seekingalpha.com |
Reports Cite Risks of Blood-Clot Devices The FDA and the Archives of Internal Medicine warn of problems associated with some devices used to keep blood clots from traveling to the lungs. online.wsj.com |
Novartis to Pay $422.5 Million to Settle Allegations: Biotech's Latest Tribulations The Burrill Report submits: Novartis Pharmaceuticals (NVS) said it reached a $422.5 million agreement with the U.S. Attorney's Office for the Eastern District of Pennsylvania regarding civil and criminal allegations of the off-label promotion of Trileptal, as well as civil allegations relating to five other products. Novartis said the payments are in line with provisions made for a potential agreement. As part of the settlement, the company will enter a Corporate Integrity Agreement with Office of the Inspector General. It will require the company to implement for five years additional compliance-related measures, which include additional monitoring, auditing, training, education, reporting and disclosures.Johnson & Johnson (JNJ) officials told a Congressional committee that it had misled consumers and regulators in its effort to quietly remove its Motrin painkiller from the market, Reuters reported. J&J is facing a criminal probe. During the hearing, the lawmakers charged that the company had placed profits over the welfare of its customers. The company, which had sought to buy back its supply of Motrin through the use of contractors posing as customers, said its McNeil unit should have alerted stores and the U.S. Food and Drug Administration to the 2009 recall.Complete Story » seekingalpha.com |
Baxter International CEO Discusses Q3 2010 Results - Earnings Call Transcript Baxter International (BAX) Q3 2020 Earnings Call October 21, 2010 8:30 a.m.Complete Story » seekingalpha.com |